Typicality: | 0.378 |
Saliency: | 0.342 |
to the participant's health | 11 | transitive-object |
to patient access to life | 9 | purpose |
in all | 4 | other |
drug → be → detrimental | 36 |
drug → be → deleterious | 3 |
negative | neutral | positive |
0.839 | 0.151 | 0.010 |
Raw frequency | 39 |
Normalized frequency | 0.342 |
Modifier score | 0.717 |
Perplexity | 88.768 |